Wall Street Journal @WSJ reporter covering drug companies, healthcare. Past: @DowJones Newswires, @LansReporter. 215-881-7127, peter.loftus@wsj.com

Thunderstorm Scatters Anti-Clinton Protesters, Who Vow to Fight On

blogs.wsj.com — A heavy thunderstorm scattered thousands of protesters away from the Democratic National Convention in Philadelphia Monday evening. But the rain didn't dampen their support for alternatives to presidential nominee Hillary Clinton. Many protesters-there to support Sen.

Philly Extends Last Call for Democratic Convention

blogs.wsj.com — PHILADELPHIA-If there are bleary-eyed delegates at next week's Democratic National Convention, consider this: last call will be later than usual in the host city. Pennsylvania Gov. Tom Wolf signed legislation last week to temporarily allow Philadelphia bars and restaurants hosting DNC-related events to serve alcohol past 2 a.m., the decades-old cutoff under state law.

Jury Acquits Former Johnson & Johnson Unit Execs of Felony Fraud

wsj.com — A federal jury in Boston on Wednesday found two former senior officers at a Johnson & Johnson division guilty of illegally marketing a medical device, but acquitted them of more serious charges including fraud, according to prosecutors and defense lawyers.

Merck & Co. Cutting Drug Research Jobs at 3 East-Coast Sites in Latest Shake-Up

wsj.com — Merck & Co. said it plans to lay off research-and-development workers at three East Coast sites in a shake-up of its early-stage drug-hunting efforts that also includes a new focus on the health effects of micro-organisms that populate the human body.

Merck Stops Development of Diabetes-Cholesterol Pill

wsj.com — Merck & Co. halted development of a pill combining its diabetes drug Januvia with a generic version of the widely used cholesterol fighter Lipitor, citing unspecified business reasons. The Whitehouse Station, N.J., company discontinued development of MK-0431E, which Merck had previously planned to submit for regulatory approval in 2014....

Even Cheap Meals Influence Doctors’ Drug Prescriptions, Study Suggests

wsj.com — It doesn't take much to get a doctor to prescribe a brand-name medication, a new study suggests. The study found that U.S. doctors who received a single free meal from a drug company were more likely to prescribe the drug the company was promoting than doctors who received no such meals.

Former Warner Chilcott Executive Acquitted of Kickbacks Charge

wsj.com — News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. W. Carl Reichel, former president of pharmaceutical unit, was accused to payoffs to doctors A jury in federal court in Boston on Friday acquitted a former executive with Allergan PLC's Warner Chilcott unit of conspiring to pay kickbacks to doctors to prod them to prescribe the company's drugs, the U.S.

Judge Sides With Gilead Against Merck in Case Over Hepatitis C Drug Patents

wsj.com — A federal judge has reversed a jury's verdict that Gilead Sciences Inc. should pay $200 million to Merck & Co. in a drug-patent dispute, after the judge concluded Merck engaged in misconduct in its efforts to obtain patents for hepatitis C drugs. U.S.

Judge throws out Merck’s $200 million verdict over Gilead

marketwatch.com — A federal judge has reversed a jury's verdict that Gilead Sciences Inc. should pay $200 million to Merck & Co. in a drug-patent dispute, after the judge concluded Merck engaged in misconduct in its efforts to obtain patents for hepatitis C drugs. U.S.

Combination Drug Therapies for Cancer Show Promise at Higher Potential Cost

nasdaq.com — By Peter Loftus CHICAGO -- Cancer researchers see promise in giving patients combinations of multiple drugs that are proving more effective than one or two. But the strategy poses a dilemma for health insurers and patients: even higher prices.
More Articles →
Sep 22, 2016

RT @pharmalot: Colorado is latest state to be sued for restricting access to hepatitis C drugs.. read lawsuit here  https://www.statnews.com/pharmalot/2016/09/22/colorado-sued-for-restricting-hepatitis-c-medicine/ 

Sep 21, 2016

Mylan CEO plans to shift the blame on the rising price of EpiPens before Congress today  http://on.wsj.com/2cCUEG7  via @WSJ @jonathanrockoff

Sep 20, 2016

@pkcapitol Wow and look at that ominous reference to Mitch Williams' pitching just weeks before... well, you know

Sep 20, 2016

Botox maker Allergan's deals since Sept. 1: -RetroSense, $60M up front -Vitae, $639M -Tobira, up to $1.7B w/CVR -Akarna, $50M up front $AGN

Sep 20, 2016

How many companies has Allergan bought in the past week? $AGN

Sep 19, 2016

RT @JeanneWhalen: CDC study found "worrisome" rise in use of powerful, 2nd-line antibiotics at U.S. hospitals 2006-2012.  http://on.wsj.com/2cWMSIY  @_melaevans

Sep 19, 2016

RT @stefaniei: Sarepta wins FDA approval for Duchenne drug, but path wasn't smooth.  http://on.wsj.com/2d5SGDc  via @WSJ

Sep 18, 2016

RT @Pervaizistan: Official: Both NYC bombs were made using pressure cookers that were filled with shrapnel including bearings & BBs. https:…


Are You a Journalist?

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.

Create a Portfolio